Effects of Efavirenz for the Treatment of HIV on the Basis of Genetic Polymorphisms
Introduction: The CYP2B6 is a liver enzyme that is involved in the metabolism of several drugs including Efavirenz, which is one of the mainstay treatments for Acquired Immunodeficiency Syndrome (AIDS), caused by the Human Immunodeficiency Virus (HIV). Polymorphisms in the CYP2B6 gene determines the...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2022-04-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://www.jcdr.net/articles/PDF/16261/52614_F(SS)_PF1(SG_SL_SHU)_PFA(Pr_SG_KM)_PN(KM).pdf |